FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557756464> ?p ?o ?g. }

• W2557756464 endingPage "825" @default.
• W2557756464 startingPage "825" @default.
• W2557756464 abstract "Abstract Background: Antithymocyteglobulin (ATG), used as conditioning regimen, can reduce graft-versus-host disease (GVHD) in haploidentical hematopoietic stem cell transplantation (haplo-HSCT). Notwithstanding, immunosuppressive effect of ATG may increase the risk of viral infections after HSCT. To evaluate the effect of different doses of ATG on post-transplant viral infection, we conducted a multicenter prospective study to compare EBV and CMV infection in haplo-HSCT recipients receiving 7.5 mg/kg or 10 mg/kg ATG. Methods Between May 2013 and November 2015, 350 consecutive patients with hematological malignancies undergoing haplo-HSCT were randomized in 5 hospitals. One hundred and seventy-two patients received ATG with a total dosage of 7.5 mg/kg and 175 received 10 mg/kg ATG. Three patients did not received allocated intervention and transplantation due to leukemia relapse before transplant or toxicity of conditioning regimens. Results The cumulative incidence of EBV viremia on day 180 was 23.3±3.2% in 7.5 mg/kg ATG arm which was lower than that in 10 mg/kg arm (34.6±3.7%, P=0.037). CMV viremia were comparable in the two arms (7.5 mg/kg arm: 79.0±3.1% vs. 10 mg/kg arm: 76.9±3.2%, P=0.950). The incidences of CMV diseases were 0.6±0.6% and 2.4±1.2% in 7.5 mg/kg and 10 mg/kg arms, respectively (P=0.093). No difference in the incidence of post-transplant lymphoproliferative disorder (PTLD) was found between the two arms (2.4±1.2% in 7.5 mg/kg arm vs. 5.4±1.8% in 10 mg/kg arm, P=0.150). Besides, acute GVHD grade II to IV within 100 days occurred in 55 recipients with the incidence of 31.4% in 7.5mg/kg ATG arms and 45 recipients in 10 mg/kg arms with the incidence of 26.2% (P=0.279). The incidences of aGVHD grade III to IV were similar in the two arms (8.0% in 7.5 mg/kg arm: vs. 4.7% in 10 mg/kg arm, P=0.196). The 2-years overall survival were 69.5±4.7% and 69.4±3.9% for 7.5 mg/kg and 10 mg/kg group (P=0.540). Conclusion Compared with 10 mg/kg of ATG, the application of 7.5 mg/kg might reduce the risk of EBV infection after haplo-HSCT and not increase aGVHD. Disclosures Lin: National Natural Science Foundation of China 81270647: Research Funding; Science and technology planning project of Guangdong Province 2014B020226004: Research Funding; The project of health collaborative innovation of Guangzhou City 201400000003-4: Research Funding; National Natural Science Foundation of China 81400141: Research Funding." @default.
• W2557756464 created "2016-12-08" @default.
• W2557756464 creator A5000828146 @default.
• W2557756464 creator A5010298865 @default.
• W2557756464 creator A5022585660 @default.
• W2557756464 creator A5023776809 @default.
• W2557756464 creator A5029592269 @default.
• W2557756464 creator A5032457247 @default.
• W2557756464 creator A5037029781 @default.
• W2557756464 creator A5041183580 @default.
• W2557756464 creator A5042449700 @default.
• W2557756464 creator A5049616921 @default.
• W2557756464 creator A5052251685 @default.
• W2557756464 creator A5053447705 @default.
• W2557756464 creator A5053706461 @default.
• W2557756464 creator A5079594267 @default.
• W2557756464 creator A5080036092 @default.
• W2557756464 date "2016-12-02" @default.
• W2557756464 modified "2023-10-16" @default.
• W2557756464 title "Influence of Lower Dose Antithymocyteglobulin As Conditioning Regimen on Viral Infection after Haploidentical Allogeneic Stem Cell Transplantation" @default.
• W2557756464 doi "https://doi.org/10.1182/blood.v128.22.825.825" @default.
• W2557756464 hasPublicationYear "2016" @default.
• W2557756464 type Work @default.
• W2557756464 sameAs 2557756464 @default.
• W2557756464 citedByCount "2" @default.
• W2557756464 countsByYear W25577564642019 @default.
• W2557756464 countsByYear W25577564642023 @default.
• W2557756464 crossrefType "journal-article" @default.
• W2557756464 hasAuthorship W2557756464A5000828146 @default.
• W2557756464 hasAuthorship W2557756464A5010298865 @default.
• W2557756464 hasAuthorship W2557756464A5022585660 @default.
• W2557756464 hasAuthorship W2557756464A5023776809 @default.
• W2557756464 hasAuthorship W2557756464A5029592269 @default.
• W2557756464 hasAuthorship W2557756464A5032457247 @default.
• W2557756464 hasAuthorship W2557756464A5037029781 @default.
• W2557756464 hasAuthorship W2557756464A5041183580 @default.
• W2557756464 hasAuthorship W2557756464A5042449700 @default.
• W2557756464 hasAuthorship W2557756464A5049616921 @default.
• W2557756464 hasAuthorship W2557756464A5052251685 @default.
• W2557756464 hasAuthorship W2557756464A5053447705 @default.
• W2557756464 hasAuthorship W2557756464A5053706461 @default.
• W2557756464 hasAuthorship W2557756464A5079594267 @default.
• W2557756464 hasAuthorship W2557756464A5080036092 @default.
• W2557756464 hasConcept C120665830 @default.
• W2557756464 hasConcept C121332964 @default.
• W2557756464 hasConcept C126322002 @default.
• W2557756464 hasConcept C159654299 @default.
• W2557756464 hasConcept C203014093 @default.
• W2557756464 hasConcept C2776185481 @default.
• W2557756464 hasConcept C2777408962 @default.
• W2557756464 hasConcept C2778461978 @default.
• W2557756464 hasConcept C2779972918 @default.
• W2557756464 hasConcept C2780611847 @default.
• W2557756464 hasConcept C2781413609 @default.
• W2557756464 hasConcept C2911091166 @default.
• W2557756464 hasConcept C61511704 @default.
• W2557756464 hasConcept C71924100 @default.
• W2557756464 hasConcept C88879693 @default.
• W2557756464 hasConcept C90924648 @default.
• W2557756464 hasConceptScore W2557756464C120665830 @default.
• W2557756464 hasConceptScore W2557756464C121332964 @default.
• W2557756464 hasConceptScore W2557756464C126322002 @default.
• W2557756464 hasConceptScore W2557756464C159654299 @default.
• W2557756464 hasConceptScore W2557756464C203014093 @default.
• W2557756464 hasConceptScore W2557756464C2776185481 @default.
• W2557756464 hasConceptScore W2557756464C2777408962 @default.
• W2557756464 hasConceptScore W2557756464C2778461978 @default.
• W2557756464 hasConceptScore W2557756464C2779972918 @default.
• W2557756464 hasConceptScore W2557756464C2780611847 @default.
• W2557756464 hasConceptScore W2557756464C2781413609 @default.
• W2557756464 hasConceptScore W2557756464C2911091166 @default.
• W2557756464 hasConceptScore W2557756464C61511704 @default.
• W2557756464 hasConceptScore W2557756464C71924100 @default.
• W2557756464 hasConceptScore W2557756464C88879693 @default.
• W2557756464 hasConceptScore W2557756464C90924648 @default.
• W2557756464 hasIssue "22" @default.
• W2557756464 hasLocation W25577564641 @default.
• W2557756464 hasOpenAccess W2557756464 @default.
• W2557756464 hasPrimaryLocation W25577564641 @default.
• W2557756464 hasRelatedWork W2080276626 @default.
• W2557756464 hasRelatedWork W2104476614 @default.
• W2557756464 hasRelatedWork W2153643980 @default.
• W2557756464 hasRelatedWork W2163095305 @default.
• W2557756464 hasRelatedWork W2307932783 @default.
• W2557756464 hasRelatedWork W2551901443 @default.
• W2557756464 hasRelatedWork W2554515299 @default.
• W2557756464 hasRelatedWork W2560664961 @default.
• W2557756464 hasRelatedWork W2587700278 @default.
• W2557756464 hasRelatedWork W2949577160 @default.
• W2557756464 hasVolume "128" @default.
• W2557756464 isParatext "false" @default.
• W2557756464 isRetracted "false" @default.
• W2557756464 magId "2557756464" @default.
• W2557756464 workType "article" @default.